Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Submitted-evidence log

Third-party data submitted to the Institute, what was submitted, by whom, and whether it was used. Data submitted and not used are recorded with the reason.

A submission that is received and not used is recorded here with the reason. A log that shows only the evidence an institution acted on cannot be used to check whether it acted on the right evidence.

The most frequent reason for not using a submission is that the provenance of the material analysed could not be established. A report on a sample whose source cannot be traced establishes something about that sample and nothing about any supplier.

Submissions

74 documents · page 1 of 3

Table 1. Evidence submissions on this page, in date order.

ReferenceReceivedWhat was submittedConcerningSubmitted byOutcome
CEI-SE/03604 Jun 2026Photographic record of a presentationImages of labelling, packaging or a vial as received.GonadorelinDr Hamish AchterbergUnder assessment
CEI-SE/02703 Jun 2026Third-party analytical reportA certificate or report from an independent laboratory.EcnoglutideDr Brigitta ZetterlundUsed — informed an assessment without citation
CEI-SE/02029 May 2026Correspondence with a supplierA documented exchange bearing on a dossier.DanuglipronDr Odalys Kirkpatrick-OlaNot used — outside scope
CEI-SE/05812 May 2026Third-party analytical reportA certificate or report from an independent laboratory.Melanotan-IIDr Clementine YlönenUsed — informed an assessment without citation
CEI-SE/06704 May 2026Batch documentationManufacturing or release documentation for a named batch.SelankDr Hamish AchterbergUnder assessment
CEI-SE/07213 Apr 2026Unpublished trial dataData from a trial not fully reported in the literature.5-amino-1MQDr Florentin VercingetorixUnder assessment
CEI-SE/03404 Apr 2026Unpublished trial dataData from a trial not fully reported in the literature.IpamorelinDr Clementine Haverkamp-DialloUsed — informed an assessment without citation
CEI-SE/04630 Mar 2026Third-party analytical reportA certificate or report from an independent laboratory.SemaglutideDr Piotr AchterbergNot used — provenance not establishable
CEI-SE/01001 Mar 2026Correspondence with a supplierA documented exchange bearing on a dossier.GHK-CuDr Ibrahim LindeqvistNot used — provenance not establishable
CEI-SE/03724 Feb 2026Regulatory assessment documentA published review document from a competent authority.DanuglipronDr Wendeline Haverkamp-DialloNot used — could not be de-identified
CEI-SE/06019 Feb 2026Unpublished trial dataData from a trial not fully reported in the literature.TirzepatideDr Benedikt Ellsworth-VanceUnder assessment
CEI-SE/07321 Dec 2025Correspondence with a supplierA documented exchange bearing on a dossier.DulaglutideDr Benedikt QuennevilleNot used — could not be de-identified
CEI-SE/00130 Nov 2025Correspondence with a supplierA documented exchange bearing on a dossier.PT-141 (bremelanotide)Dr Wojciech Fairweather-DuruUnder assessment
CEI-SE/06829 Nov 2025Certificate of analysisA supplier-issued certificate, submitted for assessment against the minimum data standard.ThymalinHamish IngelbrechtUsed — cited in a document
CEI-SE/04526 Nov 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.PT-141 (bremelanotide)Dr Wojciech Fairweather-DuruUsed — informed an assessment without citation
CEI-SE/01722 Nov 2025Batch documentationManufacturing or release documentation for a named batch.CagrilintideDr Ibrahim LindeqvistNot used — provenance not establishable
CEI-SE/02817 Nov 2025Correspondence with a supplierA documented exchange bearing on a dossier.PramlintideDr Verena UttridgeNot used — provenance not establishable
CEI-SE/00406 Nov 2025Third-party analytical reportA certificate or report from an independent laboratory.SS-31 (elamipretide)Dr Emiliana Haverkamp-DialloNot used — provenance not establishable
CEI-SE/05320 Aug 2025Unpublished trial dataData from a trial not fully reported in the literature.Maridebart cafraglutideDr Kamila QuaresmaUsed — cited in a document
CEI-SE/05015 Aug 2025Batch documentationManufacturing or release documentation for a named batch.Melanotan-IIDr Yaa Bellingham-OjoUsed — cited in a document
CEI-SE/05915 Aug 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.LiraglutideDr Vasilisa Palmgren-KofiUsed — cited in a document
CEI-SE/04131 Jul 2025Batch documentationManufacturing or release documentation for a named batch.SurvodutideDr Brigitta ZetterlundNot used — outside scope
CEI-SE/01308 Jul 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.Thymosin alpha-1Dr Odalys QuintanilhaNot used — could not be de-identified
CEI-SE/00601 Jun 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.AmycretinDr Yaa Bellingham-OjoNot used — provenance not establishable
CEI-SE/02501 May 2025Regulatory assessment documentA published review document from a competent authority.CJC-1295Dr Evander Gwynne-SarpongUnder assessment
CEI-SE/00328 Apr 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.Thymosin alpha-1Dr Nkechi VasconcelosUsed — informed an assessment without citation
CEI-SE/01913 Apr 2025Regulatory assessment documentA published review document from a competent authority.PetrelintideDr Thaddeus Glendinning-UcheNot used — could not be de-identified
CEI-SE/02601 Apr 2025Batch documentationManufacturing or release documentation for a named batch.GHRP-6Benedikt HollingworthUsed — cited in a document
CEI-SE/07114 Mar 2025Photographic record of a presentationImages of labelling, packaging or a vial as received.GonadorelinDr Yaa Bellingham-OjoUsed — cited in a document
CEI-SE/04226 Feb 2025Certificate of analysisA supplier-issued certificate, submitted for assessment against the minimum data standard.AmycretinDr Verena UttridgeNot used — could not be de-identified
Contributors consented to publication at the point of submission. The Institute publishes no submission from a person who did not consent to be named.

page 1 of 3

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.